Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 2 Trials

Atlanta, Georgia

Phase 2 colorectal cancer trials in Atlanta, GA

6 Phase 2 colorectal cancer studies are recruiting participants at sites in Atlanta as of November 18, 2026, according to ClinicalTrials.gov. Colorectal Phase 2 Trials can help you understand your options and connect with a study team.

Call (888) 467-9061
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Atlanta at a glance

  • 6 studies are recruiting at a site in Atlanta.
  • By phase: Phase 2 (6).
  • By sponsor: industry (3), university, hospital or other (3).
  • Most recent update to one of these records: November 5, 2026.

Studies recruiting in Atlanta

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Oncolytics Biotech
    Study site
    Emory Winship Cancer Institute
    Registry record
    NCT07446322 · updated
  2. Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study sites
    Emory Proton Therapy Center · Emory Saint Joseph's Hospital · Emory University Hospital Midtown
    Registry record
    NCT05673148 · updated
  3. Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Buzzard Pharmaceuticals
    Study site
    Emory University
    Registry record
    NCT06634875 · updated
  4. Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Emory University
    Study sites
    Emory Decatur Hospital · Emory Saint Joseph's Hospital · Emory University Hospital Midtown
    Registry record
    NCT07140679 · updated
  5. Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Endevica Bio
    Study site
    Piedmont Healthcare Inc.
    Registry record
    NCT06937177 · updated
  6. Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Emory University
    Study sites
    Emory Saint Joseph's Hospital · Emory University Hospital · Emory University Hospital Midtown
    Registry record
    NCT07405476 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Atlanta, GA on ClinicalTrials.gov.

Ask about studies near Atlanta

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 2, as each study is coded in the registry.

Colorectal Phase 2 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 467-9061

or send a short form

How should we reach you?

Call